secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001193125-25-073987
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics announces 1-for-13 reverse stock split effective April 8, 2025
--------------------------------------------------------------------------------

- Reverse stock split at 1:13 ratio, effective 5:00 p.m. ET on April 8, 2025.
- Pre-split shares outstanding: 45,764,184; post-split approx. 3,520,321 shares.
- No fractional shares; cash payments in lieu of fractional shares.
- Trading on Nasdaq Capital Market on split-adjusted basis from April 9, 2025.
- Proportional adjustments to warrants/options exercise prices and shares reserved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525073987/0001193125-25-073987-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525073987/d905141d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-073987

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer